Canada: Subject Screening Begins

On November 22, 2013, the first telephone screening took place in our new Canadian study of MDMA-assisted psychotherapy for 12 subjects with chronic, treatment-resistant PTSD. This marks the official start of this study, for which we worked for over five and a half years to obtain the necessary clearances from Health Canada. Goals for this study include (1) gathering evidence for the safety and effectiveness of MDMA-assisted psychotherapy for subjects with PTSD from a highly skilled co-therapist team, (2) comparing different doses of MDMA for therapeutic effectiveness and ability to create a successful double-blind, and (3) initiating the first Canadian research into the potential benefits of psychedelic psychotherapy in over 40 years.